Search
for
Sort by
Research 781–810 of 1000+
- Alopecia areata: medical treatments
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- CAQ Corner: Basic concepts of transplant immunology
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Immune therapies for alopecia areata: evidence and new perspectives
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- TREMendous Macrophages Inhibit Hair Growth
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild‐type and BK5.Akt<sup>WT</sup> mice
- CPK1 activates CNGCs through phosphorylation for Ca2+ signaling to promote root hair growth in Arabidopsis
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
- Myeloproliferative disorder associated with alopecia universalis
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up